We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Proteomics-Based Diagnostic Test Predicts Risk of Dying from Staphylococcus aureus Bacteremia

By LabMedica International staff writers
Posted on 14 Sep 2020
A diagnostic approach that integrates proteomic and metabolomic techniques enabled the identification of biomarkers that could predict which patients had the highest risk of dying from Staphylococcus aureus bacteremia.

Staphylococcus aureus bacteremia (SaB) causes significant disease in humans, carrying mortality rates of nearly 25%. More...
The ability to rapidly predict SaB patient responses and guide personalized treatment regimens could reduce mortality.

In order to develop this predictive capability, investigators at the University of California, San Diego (USA) utilized mass spectrometry (MS) to analyze more than 10,000 proteins and metabolites present in more than 200 serum samples collected from the blood of patients with SaB.

Results revealed that by integrating proteomic and metabolomic techniques, the investigators could identify more than 10,000 features from serum samples collected upon clinical presentation. The MS results demonstrated a specific pattern of proteins with and without post-translational modifications that differed in the serum of patients who ultimately died of SaB compared to those who did not. The biomarkers most highly associated with death included lower levels of glycosylated fetuin A, unmodified fetuin B, and thyroxine.

With the area under the curve (AUC) higher than 0.95, the biomarkers identified in this study greatly exceeded the predictive capabilities of those previously reported, particularly when used in combination.

"This finding is a leap forward toward a point-of-care predictive tool for bacteremia risk," said senior author Dr. David Gonzalez, assistant professor of medicine at the University of California, San Diego. "It also opens up lots of new basic biological questions about how our immune systems respond to infections. If I wanted to learn all about you, I would just talk to you directly, not your second cousin. Same thing here - we can gain new and important information by directly "asking" the proteins, rather than their genes, and mass spectrometry is currently the best way to do that in an unbiased manner."

The study was published in the September 3, 2020, online edition of the journal Cell.

Related Links:
University of California, San Diego


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Collection and Transport System
PurSafe Plus®
Blood Glucose Test Strip
AutoSense Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The TriVerity IVD test includes the TriVerity cartridge and the Myrna instrument (Photo courtesy of Inflammatix)

Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients

When a patient enters the emergency department in critical condition, clinicians must rapidly decide whether the patient has an infection, whether it is bacterial or viral, and whether immediate treatment... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.